X @Forbes
Forbes·2025-08-14 09:30
Company Overview - Celine Halioua's company has raised $135 million to develop canine longevity pills [1] Product Development - The company anticipates receiving its first conditional approval from the FDA next year for its canine longevity pills [1] Financial Highlights - The company has secured $135 million (135 million 美元) in funding from top investors [1]